Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Pupil Size After One-time Administration of NV701 (Pilocarpine 1.25%) vs. Vuity (Pilocarpine 1.25%)

NCT06783686 is registered in ClinicalTrials.gov with Novus Vision LLC as lead sponsor.

NCT NCT06783686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06783686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Pupil Size After One-time Administration of NV701 (Pilocarpine 1.25%) vs. Vuity (Pilocarpine 1.25%)
Lead sponsor
Novus Vision LLC
Phase
Phase 1
Overall status
Completed
Start date
January 30, 2025
Completion date
May 7, 2025
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pupil constriction